<p>Nasal COVID-19 vaccine halts transmission. </p><p>"Using a nasal COVID-19 vaccine based on Washington University technology, approved for use in India and licensed to Ocugen for further development in the U.S., the researchers showed that vaccinated hamsters that developed infections did not pass the virus on to others, breaking the cycle of transmission."</p><p>"This study shows that mucosal vaccines are superior to injected vaccines in terms of limiting viral replication in the upper airways and preventing spread to the next individual. In an epidemic or pandemic situation, this is the kind of vaccine you’re going to want.”</p><p>Source: <a href="https://medicine.wustl.edu/news/nasal-covid-19-vaccine-halts-transmission/" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://</span><span class="ellipsis">medicine.wustl.edu/news/nasal-</span><span class="invisible">covid-19-vaccine-halts-transmission/</span></a></p><p>Study: <a href="https://www.science.org/doi/10.1126/sciadv.adp1290" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://www.</span><span class="ellipsis">science.org/doi/10.1126/sciadv</span><span class="invisible">.adp1290</span></a></p><p><span class="h-card" translate="no"><a href="https://a.gup.pe/u/auscovid19" class="u-url mention">@<span>auscovid19</span></a></span></p>
